DJIA 16,528.03 -114.98 -0.69%
NASDAQ 4,776.51 -51.82 -1.07%
S&P 500 1,972.18 -16.69 -0.84%
market minute promo

230.60 -5.52 (-2.34%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VRX $230.60 -2.34%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $234.66
Previous Close $236.12
Daily Range $228.59 - $237.80
52-Week Range $111.41 - $263.81
Market Cap $79.0B
P/E Ratio 97.17
Dividend (Yield) $0.00 (0.0%)
Volume 1,559,132
Average Daily Volume 1,967,642
Current FY EPS $2.96




Drug Makers

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website:

News & Commentary Rss Feed

The Berkshire Hathaway of Biotech Strikes Again

Valeant Pharmaceuticals adds to its growing portfolio of products with the purchase of Sprout Pharmaceuticals. Find out what's made Valeant such a great stock to own, and what investors should be monitoring going forward.

Novogen (NVGN) Conducts Scientific Review of R&D Program

Acelity Files To Float, But Is It Secretly Seeking A Buyer?

Sequoia Fund Comments on Valeant Pt. II

Sequoia Fund Comments on Valeant Pt. II

This Week In Pharma: Keryx's Sluggish Drug Launch Vs. Excitement At Valeant And Palatin

Insider Trading Alert - VRX, WSTC And CPHD Traded By Insiders

Sucampo to Acquire R-Tech Ueno for About $278 Million

Sequoia Fund Comments on Valeant Pharmaceuticals

Glenn Greenberg Acquires Two New Stakes

Valeant Pharmaceuticals' (VRX) Charts Read Like a Textbook Bull

See More VRX News...

VRX's Top Competitors

VRX $230.60 (-2.34%)
Current stock: VRX
NVS $97.22 (-1.15%)
Current stock: NVS
JNJ $93.98 (-1.25%)
Current stock: JNJ
RHHBY $34.16 (-0.01%)
Current stock: RHHBY